Good and bad uses of the Impact Factor, a bibliometric tool;Du bon et du mauvais usage d'un indice bibliométrique, l'Impact Factor

Revue Medicale de Bruxelles

Volumn 25, Issue 1, 2004, Pages 51-54

  Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Bibliometric tool; Impact factor

Indexed keywords

CURRICULUM; MEDICAL RESEARCH; PSYCHOMETRY; PUBLICATION; QUALITY CONTROL; REVIEW; SCORING SYSTEM;

EID: 1542268312     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Similowski T, Derenne JP: Bibliométrie des périodiques médicaux. Rev Mal Respir 1995; 12: 543-50
2. Garcia-Rio F, Serrano S, Dorgham A et al: A bibliometric evaluation of European Union research of the respiratory system from 1987-1998. Eur Respir J 2001; 17: 1175-80
3. Grossi, F, Belvedere O, Rosso R: Geography of clinical cancer research publications from 1995 to 1999. Eur J Cancer 2003; 39: 106-11
4. Berghmans T, Meert AP, Mascaux C, Paesmans M, Lafitte JJ, Sculier JP: Citation indexes do not reflect methodological quality in lung cancer randomised trials. Ann Oncol 2003; 14: 715-21
5. Luce S, Paesmans M, Berghmans T et al: Revue critique des études randomisées évaluant le rôle de la radiothérapie thoracique adjuvante à la chimiothérapie dans le traitement du cancer bronchique à petites cellules au stade limité. Rev Mal Respir 1998; 15: 633-41
6. Sculier JP, Berghmans T, Castaigne C et al: Maintenance chemotherapy for small cell lung cancer: a critical review of the literature [see comments]. Lung Cancer 1998; 19: 141-51
7. Sculier JP, Berghmans T, Castaigne A et al: Best supportive care or chemotherapy for stage IV non small cell lung cancer. In: Van Houtte P, Klastersky J, Rocmans P, eds. Progress and perspectives in lung cancer. Berlin, Springer Verlag, 1999: 199-207
8. Mascaux C, Paesmans M, Berghmans T et al: A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis [In Process Citation]. Lung Cancer 2000; 30: 23-36
9. Meert AP, Berghmans T, Lafitte JJ et al: Which progress have the new agents brought for chemotherapy of advanced non-small cell lung cancer? Eur Respir Rev 2002; 208-16
10. Sculier JP, Berghmans T, Paesmans M et al: La place de la chimiothérapie dans le traitement des cancers bronchiques non à petites cellules non métastatiques. Rev Med Brux 2001; 22: 477-87
11. Sculier JP, Ghisdal L, Berghmans T et al: The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature. Br J Cancer 2001; 84: 1150-5
12. Meert AP, Paesmans M, Berghmans T et al: Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001; 1: 5
13. Berghmans T, Paesmans M, Lafitte JJ, Mascaux C, Meert AP, Sculier JP: Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer 2002; 37: 115-23
14. Chalmers TC, Smith H Jr, Blackburn B et al: A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2: 31-49